• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
    All News #Library

    4 DMT Climbs as Gene Therapy Patients Keep Jettisoning Jabs Climb

    FIERCE BIOTECH

    Sanofi pens $395M China pact for Arrowhead Metabolic med

    PRESS RELEASE

    Spine Bio Pharma Misses Primary Endpoint in Back Pain Phase 3

    FIERCE BIOTECH

    Allogene Reports Patient Death, Discontinues CAR-T Pivotal Trial

    FIERCE BIOTECH

    FDA Declines to Approve Regeneron`s Blood Cancer Drug

    REUTERS

    Poxel Changes Governance Post Reorganization Filing

    BUSINESSWIRE

    Sun Pharma Q1 Net Profit Down 20%, Revenue Up 9%

    BUSINESS STD

    Apollo Entities Request CCI Approval for Recast Plan

    ECONOMICTIMES

    Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr

    INDPHARMAPOST

    Zenara Pharma Gets FDA Nod for First Generic Sertraline

    PR NEWSWIRE

    Frazier Life Sciences raises $1.3B for early-stage biotech fund

    FIERCE BIOTECH

    Mounjaro measures up to Trulicity in Eli Lilly cardio trial

    FIERCE PHARMA

    Moderna Plans to Lay Off 10% of Workforce to Cut Costs

    REUTERS

    Bayer Adds $1.37 Billion to Roundup Litigation Reserves

    REUTERS

    Xencor Adds Raymond Deshaies, Ph.D., to Director Board

    BUSINESSWIRE

    Tandem Diabetes Care to Participate in Upcoming Conference

    BUSINESSWIRE

    Guardant Health to Join Canaccord Genuity 45th Growth Conference

    BUSINESSWIRE

    Corcept Therapeutics Reveals Q2 Financial Results and Update

    BUSINESSWIRE

    Bio-Rad`s Q2 2025 Financial Results Released

    BUSINESSWIRE

    Enpro Announces Regular Quarterly Dividend

    BUSINESSWIRE

    Aptar`s Q2 2025 Results Released

    BUSINESSWIRE

    VB Spine Debuts in Australia and New Zealand

    BUSINESSWIRE

    Regenerex Pharma Inks Licensing Deal with Holista Colltech Ltd

    BUSINESSWIRE

    LucyRx Acquires CerpassRx to Boost Clinical Excellence

    BUSINESSWIRE

    Materna Completes EASE Trial Enrollment for First-Time Moms

    BUSINESSWIRE

    iCare World USA Names Dawna Owens Strategic Partnerships Director

    BUSINESSWIRE

    Altascience, VoxCell Collaborate for Preclinical Drug Development

    BUSINESSWIRE

    Genvira, Labskin Get £1.2M UK-Canada Award for Melanoma therapies

    BUSINESSWIRE

    CareDx Reveals AI-Powered Transplant Diagnostics Data

    BUSINESSWIRE

    MindMed`s Q2 2025 Financial Results and Business Updates

    BUSINESSWIRE

    Massive Bio Launches Live Patient Connect App & AI Trial Matching

    BUSINESSWIRE

    Landon Capital Partners Sells iMemories to Ancestry

    BUSINESSWIRE

    Medicare Payment Rules Worsen Kidney Care Disparities

    BUSINESSWIRE

    Closure Systems Unveils Defender-Lok™ CRC Product Line

    BUSINESSWIRE

    BioHub Maryland Welcome Biopharma Industry Leaders` Contributions

    BUSINESSWIRE

    Sarepta Therapeutics Set to Reveal Q2 2025 Financial Results

    BUSINESSWIRE

    Study Shows Evvy`s Breakthrough in Large Bacterial Vaginosis Care

    BUSINESSWIRE

    Amylyx Pharmaceuticals` Q2 2025 Financial Results Due August 7

    BUSINESSWIRE

    Instem Acquires All Xybion Shares from Banerjee Group LLC

    BUSINESSWIRE

    DocGo Starts Mobile Vaccination Program in San Diego County

    BUSINESSWIRE

    Charles River, BioTech Social Inc. Seek Crowdfunding Partnership

    BUSINESSWIRE

    Twist Bioscience Launches Humanized Transgenic Mouse Model

    BUSINESSWIRE

    Nosis Nominates Development Candidate for Lead Fibrosis Program

    BUSINESSWIRE

    Alnylam Pharma Q2 2025 Financial Results and Recent Progress

    BUSINESSWIRE

    Dr. Keith Appointed as Meitheal Pharma`s Chief Medical Officer

    BUSINESSWIRE

    Vir Biotech Launches 2nd Global Trial for Chronic Hepatitis Delta

    BUSINESSWIRE

    Evolus` Study in JAMA Dermatology Shows Jeuveau as Top Neurotoxin

    BUSINESSWIRE

    Hyperfine Enrolls 1st Patients in AI-Powered MRI PRIME Study

    BUSINESSWIRE

    Vistagen`s Q1 2026 Results and Corporate Update Call on August 7

    BUSINESSWIRE

    Omnicell Reveals Q2 2025 Results

    BUSINESSWIRE

    Bristol Myers Squibb`s Q2 2025 Financial Results Released

    BUSINESSWIRE

    Natera`s Q2 Results to be Announced on August 7, 2025

    BUSINESSWIRE

    Exact Sciences, Humana Broaden Colorectal Cancer Screening

    BUSINESSWIRE

    FDA Approves SetPoint Medical`s Therapy for Rheumatoid Arthritis

    BUSINESSWIRE

    Baxter`s Second-Quarter 2025 Results Released

    BUSINESSWIRE

    Agenus to Share Corporate Update & Q2 2025 Financial Report

    BUSINESSWIRE

    Xeris Biopharma`s Q2 2025 Financial Results Due August 7

    BUSINESSWIRE

    Lantern Finishes Enrollment for LP-300 Lung Cancer Trial in Japan

    BUSINESSWIRE

    BeOne Gets PRIME Designation for BGB-16673 in Macroglobulinemia

    BUSINESSWIRE

    Aurinia Pharmaceuticals` Financial Results for H1 2025 Released

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.